CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | +60.0% | 8,203 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -50.0% | 8,203 | -25.4% | 0.00% | – |
| Q3 2020 | $20,000 | -82.5% | 10,993 | -19.6% | 0.00% | – |
| Q2 2020 | $114,000 | +103.6% | 13,681 | +27.3% | 0.00% | – |
| Q1 2020 | $56,000 | -13.8% | 10,749 | -9.9% | 0.00% | – |
| Q4 2019 | $65,000 | +41.3% | 11,930 | +25.2% | 0.00% | – |
| Q3 2019 | $46,000 | -30.3% | 9,529 | 0.0% | 0.00% | – |
| Q2 2019 | $66,000 | 0.0% | 9,529 | 0.0% | 0.00% | – |
| Q1 2019 | $66,000 | +37.5% | 9,529 | +16.1% | 0.00% | – |
| Q4 2018 | $48,000 | -11.1% | 8,209 | +14.7% | 0.00% | – |
| Q3 2018 | $54,000 | +50.0% | 7,158 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | -30.8% | 7,158 | -17.1% | 0.00% | – |
| Q1 2018 | $52,000 | -37.3% | 8,639 | -25.8% | 0.00% | – |
| Q4 2017 | $83,000 | -20.2% | 11,642 | -19.4% | 0.00% | – |
| Q3 2017 | $104,000 | +35.1% | 14,443 | +16.8% | 0.00% | – |
| Q2 2017 | $77,000 | – | 12,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |